Surface marker antigens in the characterization of human embryonic stem cells

Stem Cell Research

Volumn 3, Issue 1, 2009, Pages 3-11

  Wright, Andrew J ^a   Andrews, Peter W ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; CD147 ANTIGEN; CD30 ANTIGEN; CD9 ANTIGEN; DIFFERENTIATION ANTIGEN; GLOBOSIDE; GLYCOLIPID; GLYCOPROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MEMBRANE ANTIGEN; PROTEOGLYCAN; STAGE SPECIFIC EMBRYO ANTIGEN 1; STAGE SPECIFIC EMBRYO ANTIGEN 3; STAGE SPECIFIC EMBRYO ANTIGEN 4; THY 1 ANTIGEN;

ANTIGEN EXPRESSION; CELL DIFFERENTIATION; EMBRYONAL CARCINOMA; EMBRYONIC STEM CELL; HUMAN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; TERATOCARCINOMA;

ANIMALS; ANTIGENS, CD15; ANTIGENS, SURFACE; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; CELL DIFFERENTIATION; EMBRYONAL CARCINOMA STEM CELLS; GLYCOLIPIDS; HUMANS; PROTEOGLYCANS; STAGE-SPECIFIC EMBRYONIC ANTIGENS;

MURINAE;

EID: 67649827417     PISSN: 18735061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.scr.2009.04.001     Document Type: Review

References (88)

1. Andrews P.W. Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro. Dev. Biol. 103 (1984) 285-293
2. Andrews P.W., Bronson D.L., Benham F., Strickland S., and Knowles B.B. A comparative study of eight cell lines derived from human testicular teratocarcinoma. Int. J. Cancer 26 (1980) 269-280
3. Andrews P.W., Bronson D.L., Wiles M.V., and Goodfellow P.N. The expression of major histocompatibility antigens by human teratocarcinoma derived cells lines. Tissue Antigens 17 (1981) 493-500
4. Andrews P.W., Goodfellow P.N., Shevinsky L., Bronson D.L., and Knowles B.B. Cell surface antigens of a clonal human embryonal carcinoma cell line: morphological and antigenic differentiation in culture. Int. J. Cancer 29 (1982) 523-531
5. Andrews P.W., Knowles B.B., Cossu G., and Solter D. Teratocarcinoma and mouse embryo cell surface antigens: characterization of the molecules carrying the SSEA1 antigenic determinant. In: Murumatsu T., Gachelin G., Moscona A.A., and Ikawa Y. (Eds). Teratocarcinoma and embryonic Cell Interactions (1982), Japan Scientific Societies Press, Tokyo 103-119
6. Andrews P.W., Goodfellow P.N., and Bronson D.L. Cell-surface characteristics and other markers of differentiation of human teratocarcinoma cells in culture, in (1983), Martin, Strickland (Eds.), Teratocarcinoma Stem Cells, Cold Spring Harbor Press, Silver 579-590
7. Andrews P.W., Banting G.S., Damjanov I., Arnaud D., and Avner P. Three monoclonal antibodies defining distinct differentiation antigens associated with different high molecular weight polypeptides on the surface of human embryonal carcinoma cells. Hybridoma 3 (1984) 347-361
8. Andrews P.W., Damjanov I., Simon D., Banting G., Carlin C., Dracopoli N.C., and Fogh J. Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2: differentiation in vivo and in vitro. Lab. Invest. 50 (1984) 147-162
9. Andrews P.W., Meyer L.J., Bednarz K.L., and Harris H. Two monoclonal antibodies recognizing determinants on human embryonal carcinoma cells react specifically with the liver isozyme of human alkaline phosphatase. Hybridoma 3 (1984) 33-39
10. Andrews P.W., Trinchieri G., Perussia B., and Baglioni C. Induction of class 1 major histocompatibility complex antigens in human teratocarcinoma cells by interferon without induction of differentiation, growth inhibition or resistance to viral infection. Cancer Res. 47 (1987) 740-746
11. Andrews P.W., Nudelman E., Hakomori S.-I., and Fenderson B.A. Different patterns of glycolipid antigens are expressed following differentiation of TERA-2 human embryonal carcinoma cells induced by retinoic acid, hexamethylene bisacetamide (HMBA) or bromodeoxyuridine(BUdR). Differentiation 43 (1990) 131-138
12. Andrews P.W., Damjanov I., Berends J., Kumpf S., Zappavingna V., Mavilio F., and Sampath K. Inhibition of proliferation and induction of differentiation of pluripotent human embryonal carcinoma cells by osteogenic protein-1 (or bone morphogenetic protein-7). Lab. Invest. 71 (1994) 243-251
13. Andrews P.W., Casper J., Damjanov I., Duggan-Keen M., Giwercman A., Hata J.I., von Keitz A., Looijenga L.H.J., Millán J.L., Oosterhuis J.W., Pera M., Sawada M., Schmoll H.J., Skakkebaek N.E., van Putten W., and Stern P. Comparative analysis of cell surface antigens expressed by cell lines derived from human germ cell tumors. Int. J. Cancer 66 (1996) 806-816
14. Artzt K., Dubois P., Bennett D., Condamine H., Babinet C., and Jacob F. Surface antigens common to mouse cleavage embryos and primitive teratocarcinoma cells in culture. Proc. Natl. Acad. Sci. U. S. A. 70 (1973) 2988-2992
15. Bach F.H., and Amos D.B. Hu-1: major histocompatibility locus in man. Science 156 (1967) 1506-1508
16. Badcock G., Pigott C., Goepel J., and Andrews P.W. The human embryonal carcinoma marker antigen TRA-1-60 is a sialylated keratan sulphate proteoglycan. Cancer Res. 59 (1999) 4715-4719
17. Barnes, J.D., Harrison, N.J., Jones M., Baker, D., Gokhale, P.J., Andrews, P.W., in press. CD30 expression reveals that culture adaptation of human embryonic stem cells can occur through differing routes. Stem Cells.
18. Benham F.J., Andrews P.W., Bronson D.L., Knowles B.B., and Harris H. Alkaline phosphatase isozymes as possible markers of differentiation in human teratocarcinoma cell lines. Dev. Biol. 88 (1981) 279-287
19. Bernstine E.G., Hooper M.L., Grandchamp S., and Ephrussi B. Alkaline phosphatase activity in mouse teratoma. Proc. Natl. Acad. Sci. U. S. A. 70 (1973) 3899-3903
20. Bird J.M., and Kimber S.J. Oligosaccharides containing fucose linked α1→3 and α1→4 to N-acetylglucosamine cause decompaction of mouse morale. Dev. Biol. 104 (1984) 449-460
21. Boyse E.A., and Bennett D. Differentiation and the cell surface; illustrations from work with T cells and sperm. Soc. Gen. Physiol. Ser. 29 (1974) 155-176
22. Boyse E.A., and Old L.J. Some aspects of normal and abnormal cell surface genetics. Annu. Rev. Genet. 3 (1969) 269-290
23. Brimble S.N., Sherrer E.S., Uhl E.W., Wang E., Kelly S., Merrill Jr. A.H., Robins A.J., and Schulz T.C. The cell surface glycosphingolipids SSEA-3 and SSEA-4 are not essential for human ESC pluripotency. Stem Cells 25 (2006) 54-62
24. Bronson D.L., Andrews P.W., Solter D., Cervenka J., Lange P.H., and Fraley E.E. A cell line derived from a metastasis of a human testicular germ-cell tumor. Cancer Res. 40 (1980) 2500-2506
25. Buckalew J.J., Sterman B., and Rosenstraus M. Variant embryonal carcinoma cells lacking SSEA1 and Forsmann antigens remain developmentally pluripotent. Dev. Biol. 107 (1985) 134-141
26. Cantor H., and Boyse E.A. Lymphocytes as models for the study of mammalian cellular differentiation. Immunol. Rev. 33 (1977) 105-124
27. Chen C., Fenderson B.A., Andrews P.W., and Hakomori S.-I. Glycolipid-glycosyltransferases in human embryonal carcinoma cells during retinoic acid-induced differentiation. Biochemistry 28 (1989) 2229-2238
28. Childs R.A., Pennington J., Uemura K., Scudder P., Goodfellow P.N., Evans M.J., and Feizi T. High-molecular-weight glycoproteins are the major carriers of the carbohydrate differentiation antigens I, i and SSEA1 of mouse teratocarcinoma cells. Biochem. J. 215 (1983) 491-503
29. Choo A.B., Tan H.L., Ang S.N., Fong W.J., Chin A., Lo J., Zheng L., Hentze H., Philp R.J., Oh S.K., and Yap M. Selection against undifferentiated human embryonic stem cells by a cytotoxic antibody recognizing podocalyxin-like protein-1. Stem Cells 26 (2008) 1454-1463
30. Cooper S., Pera M.F., Bennett W., and Finch J.T. A novel keratan sulphateproteoglycan from a human embryonal carcinoma cell line. Biochem J. 286 (1992) 959-966
31. Cooper S., Bennett W., Andrade J., Reubinoff B.E., Thomson J., and Pera M.F. Biochemical properties of a keratan sulphate/chondroitin sulphate proteoglycan expressed in primate pluripotent stem cells. J. Anat. 200 (2002) 259-265
32. Damjanov I., and Andrews P.W. Ultrastructural differentiation of a clonal human embryonal carcinoma cell line in vitro. Cancer Res. 43 (1983) 2190-2198
33. Damjanov I., Fox N., Knowles B.B., Solter D., Lange P.H., and Fraley E.E. Immunohistochemical localization of murine stage-specific embryonic antigens in human testicular germ cell tumors. Am. J. Pathol. 108 (1982) 225-230
34. Damjanov I., Zhu Z.M., Andrews P.W., and Fenderson B.A. Embryonal carcinoma cells differentiate into parietal endoderm via an intermediate stage corresponding to primitive endoderm. In Vivo 8 (1994) 967-974
35. Draper J.S., Pigott C., Thomson J.A., and Andrews P.W. Surface antigens of human embryonic stem cells: changes upon differentiation in culture. J. Anat. 200 (2002) 249-258
36. Drukker M., Katz G., Urbach A., Schuldiner M., Markel G., Itskovitz-Eldor J., Reubinoff B., Mandelboim O., and Benvenisty N. Characterization of the expression of MHC proteins in human embryonic stem cells. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 9864-9869
37. Drukker M., Katchman H., Katz G., Even-Tov Friedman S., Shezen E., Hornstein E., Mandelboim O., Reisner Y., and Benvenisty N. Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells. Stem Cells 24 (2006) 221-229
38. Eggens I., Fenderson B., Toyokuni T., Dean B., Stroud M., and Hakomori S. Specific interaction between Lex and Lex determinants. A possible basis for cell recognition in preimplantation embryos and in embryonal carcinoma cells. J. Biol. Chem. 264 (1989) 9476-9484
39. Eisenbarth G.S., Walsh F.S., and Nirenberg M. Monoclonal antibody to a plasma membrane antigen of neurons. Proc. Natl. Acad. Sci. U. S. A. 76 (1979) 4913-4917
40. Enver T., Soneji S., Joshi C., Iborra F., Orntoft T., Thykjaer T., Maltby E., Smith K., Abu Dawd R., Matin M., Gokhale P., Draper J.S., and Andrews P.W. Cellular differentiation hierarchies in normal and culture adapted human embryonic stem cells. Hum. Mol. Genet. 14 (2005) 1-12
41. Evans M.J., and Kaufman M.H. Establishment in culture of pluripotential cells from mouse embryos. Nature 292 (1981) 154-156
42. Fenderson B.A., Zehavi U., and Hakomori S. A multivalent lacto-n-fucopentaose III-lysylysine conjugate decompacts pre-implantation-stage mouse embryos, while the free oligosaccharide is ineffective. J. Exp. Med. 160 (1984) 1591-1596
43. Fenderson B.A., Andrews P.W., Nudelman E., Clausen H., and Hakomori S.-I. Glycolipid core structure switching from globo-to lacto-and ganglio-series during retinoic acid-induced differentiation of TERA-2-derived human embryonal carcinoma cells. Dev. Biol. 122 (1987) 21-34
44. Fenderson B.A., Ostrander G., Hausken Z., Radin N.S., and Hakomori S. A ceramide analogue PDMP inhibits glycolipids synthesis in fish embryos. Exp. Cell Res. 198 (1992) 362-366
45. Fenderson B.A., Radin N., and Andrews P.W. Differentiation antigens of human germ cell tumors: distribution of carbohydrate epitopes on glycolipids and glycoproteins analysed using PDMP, an inhibitor of glycolipid synthesis. Eur. Urol. 23 (1993) 30-37
46. Fox V., Gokhale P.J., Walsh J.R., Matin M., Jones M., and Andrews P.W. Cell-cell signaling through NOTCH regulates human embryonic stem cell proliferation. Stem Cells 26 (2008) 715-723
47. Gachelin G., Delarbre C., Coulon-Morelec M.-J., Keil-Dlouha V., and Muramatsu T. F9 Antigens: A reevaluation. In: Murumatsu T., Gachelin G., Moscona A.A., and Ikawa Y. (Eds). Teratocarcinoma and Embryonic Cell Interactions (1982), Japan Scientific Societies Press, Tokyo 121-138
48. Gooi H.C., Feizi T., Kapadia A., Knowles B.B., Solter D., and Evans M.J. Stage specific embryonic antigen involves α1→3 fucosylated type 2 blood group chains. Nature 292 (1981) 156-158
49. Gregorova S., Loudova M., Dohnal K., Nosek J., and Forejt J. Establishment of a pluripotent embryonal carcinoma cell line not expressing SSEA1 and ECMA-7 phenotypes. Cell Differ. 15 (1984) 87-92
50. Henderson J.K., Draper J.S., Baillie H.S., Fishel S., Thomson J.A., Moore H., and Andrews P.W. Preiplantation human embryos and embryonic stem cells show comparable expression of stage-specific embryonic antigens. Stem Cells 20 (2002) 329-337
51. Herszfeld D., Wolvetang E., Langton-Bunker E., Chung T.L., Filipczyk A.A., Houssami S., Jamshidi P., Koh K., Laslett A.L., Michalska A., Nguyen L., Reubinoff B.E., Tellis I., Auerbach J.M., Ording C.J., Looijenga L.H., and Pera M.F. CD30 is a survival factor and a biomarker for transformed human pluripotent stem cells. Nat. Biotechnol. 24 (2006) 351-357
52. Hogan B., Fellows M., Avner P., and Jacob F. Isolation of a human teratoma cell line which expresses F9 antigen. Nature 270 (1977) 515-518
53. Holden S., Bernard O., Artzt K., Whitmore W.F., and Bennett D. Human and mouse embryonal carcinoma cells in culture share an embryonic antigen F9. Nature 270 (1977) 518-520
54. International Stem Cell Initiative (corresponding author, P.W.Andrews), Adewumi O., Aflatoonian B., Ahrlund-Richter L., Amit M., Andrews P.W., Beighton G., Bello P.A., Benvenisty N., Berry L.S., Bevan S., Blum B., Brooking J., Chen K.G., Choo A.B., Churchill G.A., Corbel M., Damjanov I., Draper J.S., Dvorak P., Emanuelsson K., Fleck R.A., Ford A., Gertow K., Gertsenstein M., Gokhale P.J., Hamilton R.S., Hampl A., Healy L.E., Hovatta O., Hyllner J., Imreh M.P., Itskovitz-Eldor J., Jackson J., Johnson J.L., Jones M., Kee K., King B.L., Knowles B.B., Lako M., Lebrin F., Mallon B.S., Manning D., Mayshar Y., McKay R.D., Michalska A.E., Mikkola M., Mileikovsky M., Minger S.L., Moore H.D., Mummery C.L., Nagy A., Nakatsuji N., O'brien C.M., Oh S.K., Olsson C., Otonkoski T., Park K.Y., Passier R., Patel H., Patel M., Pedersen R., Pera M.F., Piekarczyk M.S., Pera R.A., Reubinoff B.E., Robins A.J., Rossant J., Rugg-Gunn P., Schulz T.C., Semb H., Sherrer E.S., Siemen H., Stacey G.N., Stojkovic M., Suemori H., Szatkiewicz J., Turetsky T., Tuuri T., van den Brink S., Vintersten K., Vuoristo S., Ward D., Weaver T.A., Young L.A., and Zhang W. Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat. Biotechnol. 25 (2007) 803-816
55. Jacob F. Mouse teratocarcinoma and embryonic antigens. Immunol. Rev. 33 (1977) 3-32
56. Kannagi R. Carbohydrate-mediated cell adhesion involved in hematogenous metastasis of cancer. Glycoconj. J. 14 (1997) 577-584
57. Kannagi R., Nudelman E., Levery S.B., and Hakomori S. A series of human erythrocyte glycosphingolipids reacting to the monoclonal antibody directed to a developmentally regulated antigen, SSEA-1. J. Biol. Chem. 257 (1982) 14 865-14 874
58. Kannagi R., Cochran N.A., Ishigami F., Hakomori S.-I., Andrews P.W., Knowles B.B., and Solter D. Stage-specific embryonic antigens (SSEA-3 and-4) are epitopes of a unique globo-series ganglioside isolated from human teratocarcinoma cells. EMBO J. 2 (1983) 2355-2361
59. Kohler G., and Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256 (1975) 495-497
60. Landsteiner K. 1901 Uber Agglutinationserscheinungen normalen menschlichen Blutes, Wien. Klin.Wschr., 14, 1132-1134. [Translation: On agglutination phenomena of normal human blood, in S. H. BOYER (Ed.), 1963, Papers on Human Genetics, pp. 27-31. Prentice-Hall, Englewood Cliffs, NJ.]
61. Laslett A.L., Grimmond S., Gardiner B., Stamp L., Lin A., Hawes S.M., Wormald S., Nikolic-Paterson D., Haylock D., and Pera MF. Transcriptional analysis of early lineage commitment in human embryonic stem cells. BMC Dev. Biol. 7 (2007) 12
62. Martin G.R. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. USA 78 (1981) 7634-7636
63. Martin, G.R., and Lock, L.F. 1983. Isolation of embryonic cell lines. In: Teratocarcinoma Stem Cells ed. Silver, Martin, Strickland, Cold Spring Harbor Press, 635 - 646.
64. Matin M.M., Walsh J.R., Gokhale P.J., Draper J.S., Bahrami A., Morton I., Moore H.D., and Andrews P.W. RNA interference mediated knock-down of Oct4 expression induces differentiation of human EC and ES cells. Stem Cells 22 (2004) 659-668
65. Millán J.L., and Stigbrand T. Antigenic determinants of human placental and testicular placental-like alkaline phosphatases as mapped by monoclonal antibodies. Eur. J. Biochem. 136 (1983) 1-7
66. Muramatsu T., Gachelin G., Nicolas J.F., Condamine H., Jakob H., and Jacob F. Carbohydrate structure and cell differentitation: unique properties of fucosyl-glycopeptides isolated from embryonal carcinoma cells. Proc. Natl. Acad. Sci. U. S. A. 75 (1978) 2315-2319
67. Muramatsu T., Gachelin G., and Jacob F. Characterization of glycopeptides isolated from membranes of F9 embryonal carcinoma cells. Biochim. Biophys. Acta 587 (1979) 392-406
68. Naiki M., and Marcus D.M. Human erythrocyte P and Pk blood group antigens: identification as glycosphingolipids. Biochem. Biophys. Res. Commun. 60 (1974) 1105-1111
69. Patel R., Mickey M.R., and Terasaki P.I. Serotyping for homotransplantation. XVI. Analysis of kidney transplants from unrelated donors. N. Engl. J. Med. 279 (1968) 501-506
70. Pera M.F., Blasco-Lafita M.J., Cooper S., Mason M., Mills J., and Monaghan P. Analysis of cell-differentiation lineage in human teratomas using new monoclonal antibodies to cytostructural antigens of embryonal carcinoma cells. Differentiation 39 (1988) 139-149
71. Race R.R., and Sanger R. Blood Groups in Man. sixth ed. (1975), Blackwell Scientific, Oxford 169-171
72. Rettig W.J., Cordon-Cardo C., Ng J.S., Oettgen H.F., Old L.J., and Lloyd K.O. High-molecular-weight glycoproteins of human teratocarcinoma defined by monoclonal antibodies to carbohydrate determinants. Cancer Res. 45 (1985) 815-821
73. Reubinoff B.E., Pera M.F., Fong C.Y., Trounson A., and Bongso A. Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat. Biotechnol. 18 (2000) 399-404
74. Rosenstraus M.J. Isolation and characterization of an embryonal carcinoma cell line lacking SSEA1 antigen. Dev. Biol. 99 (1983) 318-323
75. Schopperle W.M., and DeWolf W.C. The TRA-1-60 and TRA-1-81 human pluripotent stem cell markers are expressed on podocalyxin in embryonal carcinoma. Stem Cells 25 (2007) 723-730
76. Schopperle W.M., Kershaw D.B., and DeWolf W.C. Human embryonal carcinoma tumor antigen, Gp200/GCTM-2, is podocalyxin. Biochem. Biophys. Res. Commun. 300 (2003) 285-290
77. Shevinsky L., Knowles B.B., Damjanov I., and Solter D. Monoclonal antibody to murine embryos defines a stage-specific embryonic antigen expressed on mouse embryos and human teratocarcinoma cells. Cell 30 (1982) 697-705
78. Smith C.W. Adhesion molecules and receptors. J. Allergy Clin. Immunol. 121 (2008) S375-S379
79. Solter D. From teratocarcinomas to embryonic stem cells and beyond: a history of embryonic stem cell research. Nat. Rev., Genet. 7 (2006) 319-327
80. Solter D., and Knowles B.B. Monoclonal antibody defining a stage-specific mouse embryonic antigen SSEA-1. Proc. Nat. Acad. Sci. U. S. A. 75 (1978) 5565-5569
81. Solter D., Shevinsky L., Knowles B.B., and Strickland S. The induction of antigenic changes in a teratocarcinoma stem cell line F9 by retinoic acid. Dev. Biol. 70 (1979) 515-521
82. Stern P.L., Martin G.R., and Evans M.J. Cell surface antigens of clonal teratocarcinoma cells at various stages of differentiation. Cell 6 (1975) 455-465
83. Stern P.L., Willison K.R., Lennox E., Galfre G., Milstein C., Secher D., and Ziegler A. Monoclonal antibodies as probes for differentiation and tumor-associated antigens: a Forssman specificity on teratocarcinoma stem cells. Cell 14 (1978) 775-783
84. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., and Jones J.M. Embryonic stem cell lines derived from human blastocysts. Science 282 (1998) 1145-1147
85. Thurin J., Herlyn M., Hindsgaul O., Stromberg N., Karlsson K.A., Elder D., Steplewski Z., and Koprowski H. Proton NMR and fast-atom bombardment mass spectrometry analysis of the melanoma-associated ganglioside 9-O-acetyl-GD3. J. Biol. Chem. 260 (1985) 14556-14563
86. Tippett P., Andrews P.W., Knowles B.B., Solter D., and Goodfellow P.N. Red cell antigens P (globoside) and Luke: identification by monoclonal antibodies defining the murine stage-specific embryonic antigens-3 and-4 (SSEA-3 and-4). Vox Sang 51 (1986) 53-56
87. Willison K.R., and Stern P.L. Expression of a Forssman antigenic specificity in the preimplantation mouse embryo. Cell 14 (1978) 785-793
88. Williams B.P., Daniels G.L., Pym B., Sheer D., Povey S., Okubo Y., Andrews P.W., and Goodfellow P.N. Biochemical and genetic analysis of the OK[a] blood group antigen. Immunogenetics 27 (1988) 322-329